| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human leucine rich repeat and sterile alpha motif containing 1 (LRSAM1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300920 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 3B (LRRC3B) from ORIGENE TECHNOLOGIES | TP309766 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat and sterile alpha motif containing 1 (LRSAM1), transcript variant 3 from ORIGENE TECHNOLOGIES | TP323778 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 2 (LRRC2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP316196 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 2 (LRRC2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP306380 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 20 (LRRC20), transcript variant 1 from ORIGENE TECHNOLOGIES | TP305227 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 23 (LRRC23), transcript variant 1 from ORIGENE TECHNOLOGIES | TP306514 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 32 (LRRC32), transcript variant 1 from ORIGENE TECHNOLOGIES | TP309831 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 43 (LRRC43), transcript variant 1 from ORIGENE TECHNOLOGIES | TP324832 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 61 (LRRC61), transcript variant 1 from ORIGENE TECHNOLOGIES | TP326959 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 48 (LRRC48), transcript variant 2 from ORIGENE TECHNOLOGIES | TP308501 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 61 (LRRC61), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300951 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat containing 17 (LRRC17), transcript variant 2, full length from ORIGENE TECHNOLOGIES | TP760583 | 50 ug | ORIGENE TECHNOLOGIES |
| Human leucine-rich repeat, immunoglobulin-like and transmembrane domains 2 (LRIT2) from ORIGENE TECHNOLOGIES | TP320290 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat (in FLII) interacting protein 1 (LRRFIP1), transcript variant 4 from ORIGENE TECHNOLOGIES | TP316265 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat (in FLII) interacting protein 2 (LRRFIP2), transcript variant 3 from ORIGENE TECHNOLOGIES | TP325687 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat neuronal 1 (LRRN1) from ORIGENE TECHNOLOGIES | TP305198 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine-rich repeats and calponin homology (CH) domain containing 4 (LRCH4) from ORIGENE TECHNOLOGIES | TP302263 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) from ORIGENE TECHNOLOGIES | TP323584 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine-rich repeats and transmembrane domains 2 (LRTM2) from ORIGENE TECHNOLOGIES | TP323599 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine-rich repeats and transmembrane domains 2 (LRTM2), transcript variant 2. from ORIGENE TECHNOLOGIES | TP328853 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine-rich repeats and WD repeat domain containing 1 (LRWD1) from ORIGENE TECHNOLOGIES | TP307141 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich repeat transmembrane neuronal 2 (LRRTM2) from ORIGENE TECHNOLOGIES | TP720484 | 10 ug | ORIGENE TECHNOLOGIES |
| Human leucine rich transmembrane and 0-methyltransferase domain containing (LRTOMT), transcript variant 1 from ORIGENE TECHNOLOGIES | TP302297 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine zipper, down-regulated in cancer 1 (LDOC1) from ORIGENE TECHNOLOGIES | TP300543 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine zipper and CTNNBIP1 domain containing (LZIC) from ORIGENE TECHNOLOGIES | TP309433 | 20 ug | ORIGENE TECHNOLOGIES |
| Human leucine zipper, down-regulated in cancer 1-like (LDOC1L) from ORIGENE TECHNOLOGIES | TP306668 | 20 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 2 (arylamine N-acetyltransferase) (NAT2) from ORIGENE TECHNOLOGIES | LY424976 | 100 ug | ORIGENE TECHNOLOGIES |
| Human leucine zipper protein 2 (LUZP2) from ORIGENE TECHNOLOGIES | TP321983 | 20 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY431836 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431837 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY431838 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY431839 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY424588 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 6 from ORIGENE TECHNOLOGIES | LY431840 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 7 from ORIGENE TECHNOLOGIES | LY431309 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 9 from ORIGENE TECHNOLOGIES | LY431835 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene) (NAT8B) from ORIGENE TECHNOLOGIES | LY402542 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 10 (GCN5-related) (NAT10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411178 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 8 (GCN5-related, putative) (NAT8) from ORIGENE TECHNOLOGIES | LY401303 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421227 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 9 (GCN5-related, putative) (NAT9) from ORIGENE TECHNOLOGIES | LY414415 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425958 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 2 from ORIGENE TECHNOLOGIES | LY411017 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421226 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425957 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 6 (GCN5-related) (NAT6) from ORIGENE TECHNOLOGIES | LY415920 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetyltransferase 8-like (GCN5-related, putative) (NAT8L) from ORIGENE TECHNOLOGIES | LY403615 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acylethanolamine acid amidase (NAAA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415284 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acyl phosphatidylethanolamine phospholipase D (NAPEPLD), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426574 | 100 ug | ORIGENE TECHNOLOGIES |